ADHD Medication and Predictors of Treatment Outcome
Status:
Active, not recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
ADHD medication of children and adolescents is becoming increasingly common. Clinical
experience and scientific studies have proven that approximately 30% of children/adolescents
with ADHD do not benefit from this treatment. However, there is insufficient knowledge about
who these children are. All children and adolescents, who start treatment with ADHD
medication at public Child and Adolescent Psychiatry units in Stockholm, on Gotland, an in
Västerbotten, will be asked to participate in the study. The investigators intend to monitor
the patients´clinical symptoms and possible side-effects after treatment start. The
investigators will collect background information and saliva samples from the patient and
his/her parents to be able to study if there are any genetic (hereditary) or other markers
that can predict positive or negative outcomes of the ADHD medication. With this information,
the investigators aim at, to a greater extent, be able to individualize treatment choices for
children and adolescents with ADHD without unnecessary, costly and possibly unfavorable
treatment attempts.